Wilton Bioscience

Wilton Biosciences is a preclinical-stage biotechnology company based in San Diego, California, focused on the discovery and development of novel small molecule therapeutics for oncology. The company specializes in the modulation of the ubiquitin-proteasome system, with a primary research emphasis on deubiquitinating enzymes (DUBs) such as USP7. By inhibiting USP7, Wilton Biosciences aims to stabilize key tumor suppressor proteins and enhance the immune system's ability to recognize and destroy cancer cells. Their precision medicine approach seeks to address significant unmet needs in the treatment of various solid tumors through targeted protein stabilization and degradation strategies.